Triple Twelve Pharmaceuticals Private Limited
About Triple Twelve Pharmaceuticals Private Limited
Data last updated:
Triple Twelve Pharmaceuticals Private Limited is a private limited company based in Kodungallur, Kerala, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 05 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24230KL2020PTC063441. Its GSTIN is 32AAICT0003F1Z3 (Kerala). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Padinjarekunnath Sreekumar (Managing Director) and Sithara Sreekumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No.35/473 A3 Cheraman Plaza Pallinada, Kodungallur, Kerala, India – 680664.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.91 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹54,760 (net margin 2.9%) and EBITDA of ₹84,620 (EBITDA margin 4.5%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years.
Company details
Contact details
Triple Twelve Pharmaceuticals Private Limited's registered office is in Kodungallur, Kerala. Its e-mail address is in the company report.
- Email
- Registered AddressDoor No.35/473 A3 Cheraman Plaza Pallinada, Kodungallur, Kerala, India – 680664
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Triple Twelve Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Triple Twelve Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Triple Twelve Pharmaceuticals Private Limited, buy the company report.
Financials of Triple Twelve Pharmaceuticals Private Limited
FY 2025 filings availableTriple Twelve Pharmaceuticals Private Limited reported revenue of ₹18.91 Lakh (down 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 7% over three years, including a 32% fall in the latest year. EBITDA fell 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹84,620 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹54,760 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Triple Twelve Pharmaceuticals Private Limited, buy the company report.
Board of directors of Triple Twelve Pharmaceuticals Private Limited
Triple Twelve Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sithara Sreekumar | Director | 05 Aug 2020 | 6 Years 3 Months | Current |
| Sidharth Sreekumar | Director | 05 Aug 2020 | 6 Years 3 Months | Current |
| Padinjarekunnath Sreekumar | Managing Director | 05 Aug 2020 | 6 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Triple Twelve Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Triple Twelve Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Triple Twelve Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAICT0003F1Z3 | Kerala | Active | 29 Oct 2020 |
To see the full GST registrations and return filing status of Triple Twelve Pharmaceuticals Private Limited, buy the company report.
Recent activity
Triple Twelve Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Padinjarekunnath Sreekumar was appointed as Managing Director on 05 Aug 2020.
Frequently asked questions
Triple Twelve Pharmaceuticals is an active private limited company based in Kodungallur, Kerala, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 05 August 2020 (6+ years old) and is registered under CIN U24230KL2020PTC063441.
Triple Twelve Pharmaceuticals has 3 current directors:
- Padinjarekunnath Sreekumar - Managing Director
- Sithara Sreekumar - Director
- Sidharth Sreekumar - Director
The latest financial statements of Triple Twelve Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Triple Twelve Pharmaceuticals is 32AAICT0003F1Z3, registered in Kerala. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Triple Twelve Pharmaceuticals is U24230KL2020PTC063441. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Triple Twelve Pharmaceuticals was incorporated on 05 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ernakulam.
Padinjarekunnath Sreekumar was appointed as Managing Director on 05 Aug 2020. Sidharth Sreekumar was appointed as Director on 05 Aug 2020. Sithara Sreekumar was appointed as Director on 05 Aug 2020.
The registered office of Triple Twelve Pharmaceuticals is at Door No.35473 A3 Cheraman Plaza Pallinada, Kodungallur, Kerala, India – 680664.
Triple Twelve Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Triple Twelve Pharmaceuticals can be reached at its registered office: Door No.35473 A3 Cheraman Plaza Pallinada, Kodungallur, Kerala, India – 680664.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
